SCHEMBL28024911

SCHEMBL28024911

CC(C)(C)C(=O)ON1CCC(c2ccc(N)cc2F)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.40
OPRL1 P41146 4/20 0.37
SLC9A1 P19634 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KCNH2 Q12809 1/20 0.36
MAOA P21397 1/20 0.35
NR1H2 P55055 1/20 0.35
PARP10 Q53GL7 1/20 0.35
DRD4 P21917 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
GRM2 Q14416 1/20 0.33
HCRTR2 O43614 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR3C2 P08235 1/20 0.33
ADRA1D P25100 1/20 0.33
HTR2A P28223 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27913877 0.87 PROKR1 (0.37) GPR119OPRL1MAOAHCRTR2
SCHEMBL28787308 0.86 DRD4 (0.42) GPR119OPRL1SLC9A1CYP3A4CYP2C9
SCHEMBL28024448 0.86 OPRL1 (0.36) OPRL1SLC9A1CYP3A4CYP2C9CYP2C19
SCHEMBL27948292 0.85 SLC9A1 (0.48) SLC9A1CYP3A4CYP2C9CYP2C19KCNH2
SCHEMBL28839896 0.84 NR1H2 (0.34) GPR119SLC9A1CYP3A4CYP2C9CYP2C19
SCHEMBL27790080 0.82 RBP4 (0.46) GPR119OPRL1SLC9A1CYP3A4CYP2C9
SCHEMBL6395680 0.81 GPR119 (0.56) GPR119NR1H2SMN1; SMN2
SCHEMBL29535803 0.81 GPR119 (0.56) GPR119NR1H2SMN1; SMN2
SCHEMBL15530574 0.80 HTR1D (0.39) OPRL1MAOAHTR1DHTR1BGRM2
SCHEMBL27682015 0.80 RIPK1 (0.39) PARP10CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104837835-A VEGFR3 inhibitors CANCER THERAPEUTICS CRC PTY LTD 2015-08-12 CN disclosed